<DOC>
	<DOCNO>NCT02040415</DOCNO>
	<brief_summary>The purpose clinical study determine whether DW-1030 inferior eperisone HCl efficacy safety .</brief_summary>
	<brief_title>Phase 3 Study Evaluate Efficacy Safety DW-1030 Eperisone HCl Acute Back Pain Patients</brief_title>
	<detailed_description />
	<mesh_term>Back Pain</mesh_term>
	<mesh_term>Eperisone</mesh_term>
	<criteria>Adult males/Females age 18 year Patients symptom Acute skeletomuscle myospasm Back pain Patients Pain VAS Value 40 mm Visit 2 Subjects voluntarily legal guardian agree write consent Patients Back pain cause spinal spondylosis , spinal stenosis , fracture , cancer , severe arthritis , osteoporosis , sciatica , infection Muscular patient myositis , muscular atrophy disease , increase muscle tone , myasthenia gravis Patients take invasive procedure epidural injection spinal stimulation cure back pain within 6 month screen point Patients take passive physical therapy ionphoresis within 12 hour screen point Patients severe GI tract disorder , heart disease , hypertension Patients take NSAIDS within 24hours screen point</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>